Adam Lankowski
Adam Lankowski is a commercialization manager at Bristol Myers Squibb, where he oversees the development and market introduction of innovative therapies, including the oral medication Mazigdomide, which is being studied for its potential to improve treatment outcomes for patients with multiple myeloma.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Israel:
Adam Lankowski, a commercialization manager at Bristol Myers Squibb, mentioned that doctors are excited about the new oral treatment.
7